Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' events
Dr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
ConsumerAffairs2d
Dr. Reddy’s recalls levetiracetam infusion bags nationwide due to mislabeling
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Dr. Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy’s recalls mislabelled seizure injection Levetiracetam in U.S. to consumer level
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
CNBCTV182d
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
Monthly Prescribing Reference3y
Briviact Injection
May potentiate phenytoin; monitor phenytoin levels when adding or discontinuing brivaracetam from ongoing therapy. Concomitant levetiracetam: no added benefit.
Medscape1mon
Levetiracetam for Managing Neurologic and Psychiatric Disorders
Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. Summary: Levetiracetam, an antiepileptic drug (AED), was first approved ...
Healio25d
Levetiracetam may be viable as biomarker for Alzheimer’s disease
Please provide your email address to receive an email when new articles are posted on . Levetiracetam decreased high-frequency oscillations in patients with AD and epilepsy, and increased them in ...